Document Detail


Natriuretic peptide hormone measurement in acute coronary syndromes.
MedLine Citation:
PMID:  14574059     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiac Ischemia is an important trigger for the release of B-type natriuretic peptide (BNP). BNP and N-terminal pro-BNP (N-proBNP) are emerging as important biomarkers for risk stratification in patients with acute coronary syndromes. Higher levels of BNP and pro-BNP are associated with a greater risk for death and heart failure, independent of traditional clinical variables and levels of other biomarkers such as troponins and C-reactive protein. The therapeutic implications of these findings are not yet known.
Authors:
Param Maewal; James A de Lemos
Related Documents :
7647929 - Incidence and distribution of isolated atrial amyloid: histologic and immunohistochemic...
19137789 - Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with ...
12411979 - Role of brain natriuretic peptide in the diagnosis and management of heart failure: cur...
2962199 - Atrial natriuretic peptide decreases cardiac output independent of coronary vasoconstri...
17697819 - Usefulness of preprocedural n-terminal pro-brain natriuretic peptide in predicting angi...
7634439 - Elevation of circulating and ventricular adrenomedullin in human congestive heart failure.
21532179 - Noninvasive assessment of coronary plaque using multidetector row computed tomography: ...
20129869 - Numerical methods and workstation for the quantitative analysis of real-time myocardial...
16943949 - Bundle branch reentrant ventricular tachycardia.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Heart failure reviews     Volume:  8     ISSN:  1382-4147     ISO Abbreviation:  Heart Fail Rev     Publication Date:  2003 Oct 
Date Detail:
Created Date:  2003-10-23     Completed Date:  2004-04-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9612481     Medline TA:  Heart Fail Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  365-8     Citation Subset:  IM    
Affiliation:
Donald W. Reynolds Cardiovascular Clinical Research Center and Department of Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Biological Assay
Biological Markers / analysis
Coronary Disease / diagnosis*
Heart Failure / diagnosis
Humans
Myocardial Infarction / diagnosis
Myocardial Ischemia / diagnosis
Natriuretic Peptide, Brain / analysis*
Prognosis
Risk Assessment
Chemical
Reg. No./Substance:
0/Biological Markers; 114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  B-type natriuretic peptide in heart transplantation: an important marker of allograft performance.
Next Document:  Practical considerations for BNP use.